Before COVID-19, the mortality rate for ARDS was relatively high. In 1 study looking at hospitalized patients with ARDS they reported that mortality up to 1 year was found to be 41%.1 And with the introduction of the SARS-CoV-2 pandemic, ARDS became a more common complication for COVID-19 patients with severe disease. COVID-19-related ARDS exacerbated […]

US biotech company Vaxxinity has raised the prospect of breakthroughs in treating Alzheimer’s and Parkinson’s as a result of the unprecedented resources and energy channelled into vaccine research since the start of the pandemic. Covid-19 has already resulted in the first approved mRNA-based vaccines and now Vaxxinity is developing a novel coronavirus shot using synthetic […]

Japanese pharma giant Kyowa Kirin is set to receive $400 million in a deal that wouldn’t have happened without the company’s San Diego lab. The company recently announced a partnership with Amgen to develop a drug against eczema, a skin condition that can leave painful and itchy rashes across your hands, feet and behind your […]